Making Sense Of The FDA’s ‘Indefensible’ Decision To Approve Aduhelm Giving Americans hope, even false hope, in the fight against deadly diseases has become a higher priority for the FDA than enforcing the kind of methodical, rigorous scientific testing that confirms efficacy and protects Americans against dangerous drugs.